Filer Snapshot

Telix Pharmaceuticals Ltd SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0002007191.

Entity Type

Company

Total Filings

87

Latest Filing

14 Apr 2026

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC filing 6-K

6-K filed on 14 Apr 2026 for CIK 0002007191.

View Source Filing
Symbol
TLX on Nasdaq, TLPPF on OTC
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
55 Flemington Road, North Melbourne, Australia, 3051
State of incorporation
Australia
Fiscal year end
31 December

Sponsored

Quick Takeaways

  • Telix Pharmaceuticals Ltd is an SEC filer tracked under CIK 0002007191.
  • 87 filings are listed on this profile.
  • Common form coverage includes 6-K, 4, 3 and more.

What Changed

  • Latest filing: 6-K filed on 14 Apr 2026.
  • Report period: 14 Apr 2026.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing 6-K

6-K filed on 14 Apr 2026 for CIK 0002007191.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 6-K can change the filing history, ownership context, or next research path for Telix Pharmaceuticals Ltd.

Latest source-backed update
6-K filed 14 Apr 2026
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 6-K filed 14 Apr 2026.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Telix Pharmaceuticals Ltd

New fact period available

Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

20 Feb 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 20 Feb 2026.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

Telix Pharmaceuticals Ltd has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 20 Feb 2026.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Filer Overview

Telix Pharmaceuticals Ltd has filed 87 SEC EDGAR filings since 25 Jan 2024. Common forms include 6-K, 4, 3, 20-F/A and more.

Pharmaceutical Preparations Insider transactions Latest 13F filings

Latest Filings

Recent SEC filings for Telix Pharmaceuticals Ltd with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
6-K Open 6-K document View SEC filing for 6-K 6-K 14 Apr 2026 14 Apr 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 14 Apr 2026 14 Apr 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 13 Apr 2026 12 Apr 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 10 Apr 2026 09 Apr 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 09 Apr 2026 09 Apr 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 07 Apr 2026 31 Mar 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 02 Apr 2026 01 Apr 2026 001-42128
4 Open 4 document View SEC filing for 4 FORM 4 01 Apr 2026 29 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 01 Apr 2026 18 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 01 Apr 2026 18 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 01 Apr 2026 18 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 01 Apr 2026 18 Mar 2026
20-F/A Open 20-F/A document | Open XBRL data View SEC filing for 20-F/A 20-F/A 20 Mar 2026 31 Dec 2025 001-42128
3 Open 3 document View SEC filing for 3 FORM 3 18 Mar 2026 18 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 18 Mar 2026 18 Mar 2026
3 Open 3 document View SEC filing for 3 FORM 3 18 Mar 2026 18 Mar 2026
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 16 Mar 2026 15 Mar 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 10 Mar 2026 09 Mar 2026 001-42128
F-3ASR Open F-3ASR document | Open XBRL data View SEC filing for F-3ASR F-3ASR 20 Feb 2026 333-293611
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F 20-F 20 Feb 2026 31 Dec 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 19 Feb 2026 17 Feb 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 18 Feb 2026 17 Feb 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 03 Feb 2026 02 Feb 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 20 Jan 2026 19 Jan 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 12 Jan 2026 12 Jan 2026 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 22 Dec 2025 21 Dec 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 17 Dec 2025 17 Dec 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 08 Dec 2025 07 Dec 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 14 Oct 2025 14 Oct 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 23 Sep 2025 22 Sep 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 09 Sep 2025 08 Sep 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 28 Aug 2025 04 Aug 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 21 Aug 2025 20 Aug 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 22 Jul 2025 22 Jul 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 09 Jul 2025 08 Jul 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 11 Jun 2025 11 Jun 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 21 May 2025 20 May 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 29 Apr 2025 27 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 22 Apr 2025 22 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 17 Apr 2025 16 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 17 Apr 2025 15 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 08 Apr 2025 06 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 04 Apr 2025 03 Apr 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K 21 Mar 2025 20 Mar 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 18 Mar 2025 17 Mar 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 12 Mar 2025 11 Mar 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 27 Feb 2025 25 Feb 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 26 Feb 2025 25 Feb 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 25 Feb 2025 25 Feb 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 24 Feb 2025 24 Feb 2025 001-42128
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F 20-F 24 Feb 2025 31 Dec 2024 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 21 Feb 2025 20 Feb 2025 001-42128
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94874
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94874
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 13 Feb 2025 12 Feb 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 31 Jan 2025 30 Jan 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K 27 Jan 2025 27 Jan 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 17 Jan 2025 16 Jan 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 13 Jan 2025 13 Jan 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 13 Jan 2025 12 Jan 2025 001-42128
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS 30 Dec 2024 29 Dec 2024 001-42128
S-8 Open S-8 document View SEC filing for S-8 S-8 19 Dec 2024 333-283917
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 21 Nov 2024
6-K Open 6-K document View SEC filing for 6-K 6-K 19 Nov 2024 19 Nov 2024 001-42128
6-K Open 6-K document View SEC filing for 6-K 6-K 14 Nov 2024 12 Nov 2024 001-42128
EFFECT Open EFFECT document View SEC filing for EFFECT 12 Nov 2024 333-282705
SEC STAFF ACTION Open SEC STAFF ACTION document View SEC filing for SEC STAFF ACTION 12 Nov 2024
CERT Open CERT document View SEC filing for CERT 12 Nov 2024 001-42128
CORRESP Open CORRESP document View SEC filing for CORRESP 12 Nov 2024
20FR12B/A Open 20FR12B/A document View SEC filing for 20FR12B/A 20FR12B/A 30 Oct 2024 001-42128
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 28 Oct 2024
F-6 Open F-6 document View SEC filing for F-6 17 Oct 2024 333-282705
CORRESP Open CORRESP document View SEC filing for CORRESP 17 Oct 2024
20FR12B Open 20FR12B document View SEC filing for 20FR12B 20FR12B 17 Oct 2024 001-42128
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 10 Oct 2024 377-07439
DRS Open DRS document View SEC filing for DRS 13 Sep 2024 377-07439
RW Open RW document View SEC filing for RW RW 14 Jun 2024 333-279808
RW Open RW document View SEC filing for RW RW 14 Jun 2024 333-279471
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 10 Jun 2024 001-42128
F-1/A Open F-1/A document View SEC filing for F-1/A F-1/A 05 Jun 2024 333-279471
F-6 Open F-6 document View SEC filing for F-6 30 May 2024 333-279808
F-1 Open F-1 document View SEC filing for F-1 F-1 17 May 2024 333-279471
DRS/A Open DRS/A document View SEC filing for DRS/A 09 May 2024 377-07070
DRS/A Open DRS/A document View SEC filing for DRS/A 15 Apr 2024 377-07070
DRS/A Open DRS/A document View SEC filing for DRS/A 15 Mar 2024 377-07070
DRS/A Open DRS/A document View SEC filing for DRS/A 02 Feb 2024 377-07070
DRS Open DRS document View SEC filing for DRS 25 Jan 2024 377-07070

About this filer

Telix Pharmaceuticals Ltd files with the SEC under CIK 0002007191. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Sponsored